Concepedia

Oshrat Hershkovitz‐Rokah

OH

10

Publications

365

Citations

10

H-Index

2010

Active since

Affiliations

Assuta Medical Center(Current)

Ariel University

Tel Aviv University

Memorial Sloan Kettering Cancer Center

Edmond and Lily Safra Children's Hospital

Oshrat Hershkovitz‐Rokah is an author at Assuta Medical Center specializing in immunology, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2010–2024

10

Publications

10

Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells

Oshrat Hershkovitz‐Rokah, Galit Granot, Adelina Ovcharenko et al. · PLoS ONE · 2012 · 101 citations · Full text

MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein

Oshrat Hershkovitz‐Rokah, Shira Modai, Metsada Pasmanik‐Chor et al. · Cancer Letters · 2014 · 81 citations

, , +13

Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment

Oshrat Hershkovitz‐Rokah, Shira Modai, Metsada Pasmanik‐Chor et al. · Cancer Letters · 2015 · 63 citations

, , +7

MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis

Ran Weissman, Eli L. Diamond, Julien Haroche et al. · Leukemia · 2021 · 24 citations · Full text

NAD(P)H Quinone Oxidoreductase Protects TAp63γ from Proteasomal Degradation and Regulates TAp63γ-Dependent Growth Arrest

Oshrat Hershkovitz‐Rokah, Ofer Shpilberg, Galit Granot · PLoS ONE · 2010 · 22 citations · Full text

Rows per page

1–5 of 10